Researchers review the reemergence and range expansion of Oropouche virus in South America, highlighting risks of spread to the U.S. and need for improved diagnostic tests. Over 9,000 cases and two deaths were reported in 2024.
FDA converts accelerated to full approval for Padcev-Keytruda combo in bladder cancer
The FDA on Friday granted full approval to Seagen and Astellas Pharma’s Padcev (enfortumab vedotin-ejfv) in combo with Merck’s Keytruda (pembrolizumab) for patients with locally